Promotion of axonal maturation and prevention of memory loss in mice by extracts of <i>Astragalus mongholicus</i>

抄録

<jats:sec><jats:title>Background and purpose:</jats:title><jats:p>Neurons with atrophic neurites may remain alive and therefore may have the potential to regenerate even when neuronal death has occurred in some parts of the brain. This study aimed to explore effects of drugs that can facilitate the regeneration of neurites and the reconstruction of synapses even in severely damaged neurons.</jats:p></jats:sec><jats:sec><jats:title>Experimental approach:</jats:title><jats:p>We investigated the effects of extracts of <jats:italic>Astragalus mongholicus</jats:italic> on the cognitive defect in mice caused by injection with the amyloid peptide Aβ(25‐35). We also examined the effect of the extract on the regeneration of neurites and the reconstruction of synapses in cultured neurons damaged by Aβ(25‐35).</jats:p></jats:sec><jats:sec><jats:title>Key results:</jats:title><jats:p><jats:italic>A. mongholicus</jats:italic> extract (1 g kg<jats:sup>−1</jats:sup> day<jats:sup>−1</jats:sup> for 15 days, p.o.) reversed Aβ(25‐35)‐induced memory loss and prevented the loss of axons and synapses in the cerebral cortex and hippocampus in mice. Treatment with Aβ(25‐35) (10 μM) induced axonal atrophy and synaptic loss in cultured rat cortical neurons. Subsequent treatment with <jats:italic>A. mongholicus</jats:italic> extract (100 μg/ml) resulted in significant axonal regeneration, reconstruction of neuronal synapses, and prevention of Aβ(25‐35)‐induced neuronal death. Similar extracts of <jats:italic>A. membranaceus</jats:italic> had no effect on axonal atrophy, synaptic loss, or neuronal death. The major known components of the extracts (astragalosides I, II, and IV) reduced neurodegeneration, but the activity of the extracts did not correlate with their content of these three astragalosides.</jats:p></jats:sec><jats:sec><jats:title>Conclusion and implications:</jats:title><jats:p><jats:italic>A. mongholicus</jats:italic> is an important candidate for the treatment of memory disorders and the main active constituents may not be the known astragalosides.</jats:p><jats:p><jats:italic>British Journal of Pharmacology</jats:italic> (2006) <jats:bold>149</jats:bold>, 532–541. doi:<jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1038/sj.bjp.0706865">10.1038/sj.bjp.0706865</jats:ext-link></jats:p></jats:sec>

収録刊行物

被引用文献 (12)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ